# A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

> **NCT00435929** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 16 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Ritonavir
- **DRUG:** saquinavir [Invirase]

## Key facts

- **NCT ID:** NCT00435929
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435929, "A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00435929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*